AIRS (AirSculpt Technologies) EBIT: $-11.6 Mil (TTM As of Mar. 2026)


AIRS AirSculpt Technologies Inc AIRS
73 GF Score
Price $4.55
GF Value $3.93
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is AirSculpt Technologies EBIT?

AirSculpt Technologies AIRS -1.20% 73 EBIT is $-11.6 Mil as of Mar. 2026. GuruFocus rates AIRS with a GF Score™ of 73/100 and a GF Value™ of $3.93 (Modestly Overvalued). The stock has 3 warning signs investors should review.

AirSculpt Technologies's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-1.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-11.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. AirSculpt Technologies's annualized ROC % for the quarter that ended in Mar. 2026 was -3.25%. AirSculpt Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -13.65%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. AirSculpt Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -3.10%.

AirSculpt Technologies  (NAS:AIRS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

AirSculpt Technologies's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-7.208 * ( 1 - 16.25% )/( (186.477 + 185.073)/ 2 )
=-6.0367/185.775
=-3.25 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=187.304 - 13.273 - ( 8.449 - max(0, 27.902 - 15.456+8.449))
=186.477

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=191.999 - 15.077 - ( 16.69 - max(0, 32.481 - 24.33+16.69))
=185.073

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

AirSculpt Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-6.656/( ( (50.269 + max(-9.636, 0)) + (47.261 + max(-14.178, 0)) )/ 2 )
=-6.656/( ( 50.269 + 47.261 )/ 2 )
=-6.656/48.765
=-13.65 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 5.508) - (13.273 + 1.871 + 3.5527136788005E-15)
=-9.636

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 5.666) - (15.077 + 3.9 + 0.867)
=-14.178

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

AirSculpt Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-11.635/374.955
=-3.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AirSculpt Technologies EBIT Related Terms

AirSculpt Technologies EBIT Historical Data

* Premium members only.

The historical data trend for AirSculpt Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AirSculpt Technologies EBIT Chart

AirSculpt Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 15.77 -4.55 9.72 -1.58 -11.56

AirSculpt Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.59 0.79 -9.75 -1.01 -1.66

AIRS vs CYH, CCRN, AUNA: EBIT Comparison

For the Medical Care Facilities subindustry, AirSculpt Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AirSculpt Technologies EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where AirSculpt Technologies's EV-to-EBIT falls into.


AIRS
73GF Score
AirSculpt Technologies Inc AIRS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AirSculpt Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-11.6 Mil mean?
AirSculpt Technologies (AIRS) has a EBIT of $-11.6 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on AirSculpt Technologies.
Is AirSculpt Technologies' EBIT too high?
AirSculpt Technologies' current EBIT is $-11.6 Mil. Overall, AirSculpt Technologies has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' EBIT compare to CYH and CCRN?
AirSculpt Technologies' EBIT of $-11.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on AirSculpt Technologies. AirSculpt Technologies's current EBIT is $-11.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.93, compared to a current price of $4.55 — trading 15.8% above its estimated fair value. The current EBIT is $-11.6 Mil. AirSculpt Technologies' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current EBIT is $-11.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AirSculpt Technologies (AIRS) Overvalued in 2026?

Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued. The current stock price of $4.55 is trading 15.8% above its estimated GF Value™ of $3.93. GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.

Key valuation signals for AIRS:

  • EBIT: $-11.6 Mil
  • GF Value™: $3.93 vs. price of $4.55 (15.8% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AirSculpt Technologies Business Description

Address 1111 Lincoln Road, Suite 802, Miami Beach, FL, USA, 33139
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
73GF Score

Get the complete analysis for AIRS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.55
Price
$3.93
GF Value